Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Tumorigenesis: Cancer as a symptom of evolution?

Alderton GK.

Nat Rev Cancer. 2017 Jun;17(6):373. doi: 10.1038/nrc.2017.33. Epub 2017 May 5. No abstract available.

PMID:
28474690
2.

Immunotherapy: Engineered T cells for all.

Alderton GK.

Nat Rev Cancer. 2017 Apr;17(4):206-207. doi: 10.1038/nrc.2017.19. Epub 2017 Mar 3. No abstract available.

PMID:
28256575
3.

Tumour evolution: Epigenetic and genetic heterogeneity in metastasis.

Alderton GK.

Nat Rev Cancer. 2017 Feb 23;17(3):141. doi: 10.1038/nrc.2017.11. No abstract available.

PMID:
28228644
4.

Metastasis: Planting metastasis early.

Alderton GK.

Nat Rev Cancer. 2017 Jan 27;17(2):75. doi: 10.1038/nrc.2017.4. No abstract available.

PMID:
28127045
5.

Cancer risk: Generating tumours: it's all in the balance.

Alderton GK.

Nat Rev Cancer. 2016 Nov 23;16(12):753. doi: 10.1038/nrc.2016.137. No abstract available.

PMID:
27876777
6.

Tumour microenvironment: Obesity promotes prostate cancer invasion.

Alderton GK.

Nat Rev Cancer. 2016 Jan 29;16(2):70. doi: 10.1038/nrc.2016.129. No abstract available.

PMID:
27834947
7.

Immunology: Skin inflammation predisposes to cancer.

Alderton GK.

Nat Rev Cancer. 2016 Oct 24;16(11):678. doi: 10.1038/nrc.2016.120. No abstract available.

PMID:
27775068
8.

Tumour metabolism: Targeting proline metabolism?

Alderton GK.

Nat Rev Cancer. 2016 Oct 24;16(11):678. doi: 10.1038/nrc.2016.119. No abstract available.

PMID:
27775067
9.

Tumour evolution: Evolving resistance in Tasmanian devils.

Alderton GK.

Nat Rev Cancer. 2016 Sep 23;16(10):617. doi: 10.1038/nrc.2016.103. No abstract available.

PMID:
27658634
10.

Tumour immunology: Another string to the MYC bow.

Alderton GK.

Nat Rev Cancer. 2016 Apr 26;16(5):273. doi: 10.1038/nrc.2016.47. No abstract available.

PMID:
27112205
11.

Translocations: Circular RNAs from translocations.

Alderton GK.

Nat Rev Cancer. 2016 Apr 26;16(5):273. doi: 10.1038/nrc.2016.48. No abstract available.

PMID:
27112204
12.

Tumour metabolism: Feeding the TCA cycle in vivo.

Alderton GK.

Nat Rev Cancer. 2016 Apr;16(4):198. doi: 10.1038/nrc.2016.29. No abstract available.

PMID:
27009387
13.

Cancer risk: Debating the odds.

Alderton GK.

Nat Rev Cancer. 2016 Feb;16(2):68. doi: 10.1038/nrc.2016.5. Epub 2016 Jan 22. No abstract available.

PMID:
26797649
14.

Tumour immunology: Intestinal bacteria are in command.

Alderton GK.

Nat Rev Cancer. 2016 Jan;16(1):4. doi: 10.1038/nrc.2015.8. Epub 2015 Dec 15. Review. No abstract available.

PMID:
26667850
15.

Tumour immunology: Intestinal bacteria are in command.

Alderton GK.

Nat Rev Immunol. 2016 Jan;16(1):5. doi: 10.1038/nri.2015.13. Epub 2015 Dec 14. No abstract available.

PMID:
26655627
16.

Metastasis: Directions to metastatic sites.

Alderton GK.

Nat Rev Cancer. 2015 Dec;15(12):696-7. doi: 10.1038/nrc4046. Epub 2015 Nov 13. No abstract available.

PMID:
26563464
17.

Therapeutic resistance: Multiple mechanisms to keep going.

Alderton GK.

Nat Rev Cancer. 2015 Nov;15(11):635. doi: 10.1038/nrc4034. No abstract available.

PMID:
26493640
18.

MYC: Splicing up your survival.

Alderton GK.

Nat Rev Cancer. 2015 Oct;15(10):574-5. doi: 10.1038/nrc4013. Epub 2015 Sep 18. No abstract available.

PMID:
26383137
19.

Autophagy: Surviving stress in pancreatic cancer.

Alderton GK.

Nat Rev Cancer. 2015 Sep;15(9):513. doi: 10.1038/nrc4005. No abstract available.

PMID:
26299587
20.

Diagnosis: Fishing for exosomes.

Alderton GK.

Nat Rev Cancer. 2015 Aug;15(8):453. doi: 10.1038/nrc3990. No abstract available.

PMID:
26205334
21.

Haematological malignancies: Splicing the MDS genome.

Alderton GK.

Nat Rev Cancer. 2015 Jul;15(7):393. doi: 10.1038/nrc3975. No abstract available.

PMID:
26105536
22.

Therapeutic resistance: Fibroblasts restrain drug sensitivity.

Alderton GK.

Nat Rev Cancer. 2015 Jun;15(6):318-9. doi: 10.1038/nrc3965. No abstract available.

PMID:
25998706
23.

Metastasis: Spreading the seed.

Alderton GK.

Nat Rev Cancer. 2015 May;15(5):255. doi: 10.1038/nrc3953. No abstract available.

PMID:
25907213
24.

Heterogeneity: Explosive beginnings.

Alderton GK.

Nat Rev Cancer. 2015 Apr;15(4):198-9. doi: 10.1038/nrc3928. No abstract available.

PMID:
25801613
25.

Tumour microenvironment: Driving relapse.

Alderton GK.

Nat Rev Cancer. 2015 Apr;15(4):195. doi: 10.1038/nrc3935. No abstract available.

PMID:
25801612
26.

Metabolism: acetate nourishes stressed tumour cells.

Alderton GK.

Nat Rev Cancer. 2015 Feb;15(2):67. doi: 10.1038/nrc3899. No abstract available.

PMID:
25613999
27.

Tumour evolution: clonal ancestry in lung cancer.

Alderton GK.

Nat Rev Cancer. 2014 Dec;14(12):763. No abstract available.

PMID:
25568921
28.

Epigenetics: Histone methylation: it's in the numbers.

Alderton GK.

Nat Rev Cancer. 2015 Jan;15(1):1. doi: 10.1038/nrc3883. No abstract available.

PMID:
25533665
29.

Metastasis: metabolic reprogramming in disseminated cells.

Alderton GK.

Nat Rev Cancer. 2014 Nov;14(11):703. doi: 10.1038/nrc3842. Epub 2014 Oct 16. No abstract available.

PMID:
25319868
30.

Anticancer drugs: using CTCs to test drug sensitivity.

Alderton GK.

Nat Rev Drug Discov. 2014 Sep;13(9):654. doi: 10.1038/nrd4420. No abstract available.

PMID:
25176433
31.

Tumorigenesis: FBP1 is suppressed in kidney tumours.

Alderton GK.

Nat Rev Cancer. 2014 Sep;14(9):575. doi: 10.1038/nrc3810. No abstract available.

PMID:
25145476
32.

Therapy: using CTCs to test drug sensitivity.

Alderton GK.

Nat Rev Cancer. 2014 Sep;14(9):576. doi: 10.1038/nrc3799. Epub 2014 Jul 31. No abstract available.

PMID:
25079656
33.

Transcription: The transcriptional effects of MYC.

Alderton GK.

Nat Rev Cancer. 2014 Aug;14(8):513. doi: 10.1038/nrc3790. No abstract available.

PMID:
25056701
34.

Immunotherapy: two hits are better than one.

Alderton GK.

Nat Rev Immunol. 2014 Jul;14(7):431. doi: 10.1038/nri3710. No abstract available.

PMID:
24962259
35.

Immunotherapy: Two hits are better than one.

Alderton GK.

Nat Rev Cancer. 2014 Jul;14(7):451. doi: 10.1038/nrc3777. Epub 2014 Jun 19. No abstract available.

PMID:
24943810
36.

Microenvironment: An exercise in restraint.

Alderton GK.

Nat Rev Cancer. 2014 Jul;14(7):449. doi: 10.1038/nrc3769. Epub 2014 Jun 5. No abstract available.

PMID:
24898060
37.

Metastasis: shedding is no easy task.

Alderton GK.

Nat Rev Cancer. 2014 Jun;14(6):383. doi: 10.1038/nrc3755. No abstract available.

PMID:
24854076
38.

DNA damage: De-sanitizing tumour cells.

Alderton GK.

Nat Rev Cancer. 2014 May;14(5):296. doi: 10.1038/nrc3734. Epub 2014 Apr 17. No abstract available.

PMID:
24739574
39.

Pluripotency: partial reprogramming induces cancer.

Alderton GK.

Nat Rev Cancer. 2014 Apr;14(4):216-7. doi: 10.1038/nrc3713. No abstract available.

PMID:
24658270
40.

Tumour immunology: turning macrophages on, off and on again.

Alderton GK.

Nat Rev Immunol. 2014 Mar;14(3):136-7. doi: 10.1038/nri3634. No abstract available.

PMID:
24566906
41.

Resistance: turning macrophages on, off and on again.

Alderton GK.

Nat Rev Cancer. 2014 Mar;14(3):154-5. doi: 10.1038/nrc3688. No abstract available.

PMID:
24561433
42.

Genomics: Seek and you shall find...

Alderton GK.

Nat Rev Cancer. 2014 Feb;14(2):75. doi: 10.1038/nrc3675. No abstract available.

PMID:
24457415
43.

Tumour microenvironment: To me, to you.

Alderton G.

Nat Rev Cancer. 2013 Nov;13(11):756-7. doi: 10.1038/nrc3618. Epub 2013 Oct 17. No abstract available.

PMID:
24132102
44.

Genomics: Mutator catalogues.

Alderton GK.

Nat Rev Cancer. 2013 Oct;13(10):681. doi: 10.1038/nrc3608. No abstract available.

PMID:
24060860
45.

Metastasis: Active lymph nodes.

Alderton GK.

Nat Rev Cancer. 2013 Sep;13(9):606-7. doi: 10.1038/nrc3587. No abstract available.

PMID:
23969687
46.

Metastasis: Exit this way.

Alderton GK.

Nat Rev Cancer. 2013 Aug;13(8):523. doi: 10.1038/nrc3571. Epub 2013 Jul 18. No abstract available.

PMID:
23864051
47.

Tumour suppression: No contact please.

Alderton GK.

Nat Rev Cancer. 2013 Aug;13(8):522. doi: 10.1038/nrc3568. Epub 2013 Jul 4. No abstract available.

PMID:
23822980
48.

Tumour heterogeneity: The rise of the minority.

Alderton GK.

Nat Rev Cancer. 2013 Apr;13(4):225. doi: 10.1038/nrc3499. No abstract available.

PMID:
23518702
49.

Genomic instability: DNA transitions.

Alderton GK.

Nat Rev Cancer. 2013 Apr;13(4):220-1. doi: 10.1038/nrc3490. Epub 2013 Mar 14. No abstract available.

PMID:
23486239
50.

Tumour immunology: Give it a rest.

Alderton GK.

Nat Rev Immunol. 2013 Mar;13(3):156-7. doi: 10.1038/nri3414. No abstract available.

PMID:
23435330

Supplemental Content

Loading ...
Support Center